Yuhan Future Growth
Future criteria checks 2/6
Yuhan is forecast to grow earnings and revenue by 21.9% and 9.3% per annum respectively. EPS is expected to grow by 20.9% per annum. Return on equity is forecast to be 9.8% in 3 years.
Key information
21.9%
Earnings growth rate
20.9%
EPS growth rate
Pharmaceuticals earnings growth | 33.3% |
Revenue growth rate | 9.3% |
Future return on equity | 9.8% |
Analyst coverage | Good |
Last updated | 16 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,485,917 | 244,105 | 253,780 | 259,346 | 16 |
12/31/2025 | 2,283,485 | 195,043 | 217,405 | 222,300 | 16 |
12/31/2024 | 2,095,987 | 136,015 | 91,122 | 161,831 | 11 |
9/30/2024 | 2,008,841 | 165,686 | -93,593 | 59,730 | N/A |
6/30/2024 | 1,893,119 | 147,849 | -75,289 | 100,417 | N/A |
3/31/2024 | 1,860,529 | 124,466 | -80,670 | 110,014 | N/A |
12/31/2023 | 1,858,984 | 133,993 | -59,775 | 144,128 | N/A |
9/30/2023 | 1,872,336 | 88,109 | -59,302 | 113,301 | N/A |
6/30/2023 | 1,820,811 | 76,045 | -94,824 | 48,972 | N/A |
3/31/2023 | 1,808,041 | 101,446 | -18,662 | 106,905 | N/A |
12/31/2022 | 1,775,847 | 95,144 | -2,356 | 99,529 | N/A |
9/30/2022 | 1,749,315 | 74,669 | 21,500 | 112,004 | N/A |
6/30/2022 | 1,769,245 | 97,836 | 64,662 | 146,027 | N/A |
3/31/2022 | 1,719,630 | 97,911 | -77,146 | 1,983 | N/A |
12/31/2021 | 1,687,810 | 102,583 | 17,726 | 99,000 | N/A |
9/30/2021 | 1,725,261 | 98,128 | -40,214 | 63,556 | N/A |
6/30/2021 | 1,703,475 | 97,833 | -90,028 | 16,218 | N/A |
3/31/2021 | 1,685,623 | 97,578 | 33,086 | 125,628 | N/A |
12/31/2020 | 1,619,865 | 192,761 | -55,854 | 28,830 | N/A |
9/30/2020 | 1,552,188 | 184,730 | -12,076 | 40,572 | N/A |
6/30/2020 | 1,504,765 | 168,667 | 95,017 | 136,587 | N/A |
3/31/2020 | 1,448,677 | 140,227 | -32,349 | 12,995 | N/A |
12/31/2019 | 1,480,354 | 40,006 | 19,251 | 65,985 | N/A |
9/30/2019 | 1,500,782 | 44,230 | 22,262 | 71,414 | N/A |
6/30/2019 | 1,497,130 | 41,438 | -43,955 | 1,332 | N/A |
3/31/2019 | 1,523,954 | 52,333 | 109,427 | 156,727 | N/A |
12/31/2018 | 1,518,823 | 57,481 | 45,602 | 93,452 | N/A |
9/30/2018 | 1,481,906 | 70,146 | 54,109 | 108,573 | N/A |
6/30/2018 | 1,482,034 | 84,572 | N/A | 107,587 | N/A |
3/31/2018 | 1,450,870 | 100,288 | N/A | 112,160 | N/A |
12/31/2017 | 1,462,248 | 109,034 | N/A | 126,125 | N/A |
9/30/2017 | 1,434,749 | 139,325 | N/A | 116,234 | N/A |
6/30/2017 | 1,417,835 | 137,434 | N/A | 135,085 | N/A |
3/31/2017 | 1,395,518 | 139,440 | N/A | 142,224 | N/A |
12/31/2016 | 1,320,797 | 161,249 | N/A | 74,144 | N/A |
9/30/2016 | 1,274,011 | 134,997 | N/A | 98,827 | N/A |
6/30/2016 | 1,223,925 | 155,819 | N/A | 97,292 | N/A |
3/31/2016 | 1,163,130 | 152,682 | N/A | 88,684 | N/A |
12/31/2015 | 1,128,731 | 126,047 | N/A | 126,235 | N/A |
9/30/2015 | 1,097,229 | 118,104 | N/A | 120,389 | N/A |
6/30/2015 | 1,046,716 | 98,362 | N/A | 140,058 | N/A |
3/31/2015 | 1,031,875 | 94,628 | N/A | 71,402 | N/A |
12/31/2014 | 1,017,492 | 90,948 | N/A | 94,386 | N/A |
9/30/2014 | 1,007,109 | 95,434 | N/A | 78,642 | N/A |
6/30/2014 | 970,253 | 87,696 | N/A | 44,515 | N/A |
3/31/2014 | 953,191 | 83,863 | N/A | 56,486 | N/A |
12/31/2013 | 943,609 | 86,461 | N/A | 79,778 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A000105's forecast earnings growth (21.9% per year) is above the savings rate (2.7%).
Earnings vs Market: A000105's earnings (21.9% per year) are forecast to grow slower than the KR market (28.4% per year).
High Growth Earnings: A000105's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A000105's revenue (9.3% per year) is forecast to grow slower than the KR market (9.4% per year).
High Growth Revenue: A000105's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A000105's Return on Equity is forecast to be low in 3 years time (9.8%).